Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 2000 Dec;84(12):1383–1386. doi: 10.1136/bjo.84.12.1383

Diode laser treatment of posterior retinopathy of prematurity

R Axer-Siegel 1, M Snir 1, D Cotlear 1, A Maayan 1, R Frilling 1, I Rosenbaltt 1, D Weinberger 1, I Kremer 1, L Sirota 1
PMCID: PMC1723330  PMID: 11090478

Abstract

AIMS—To study the efficacy of infrared diode laser for the treatment of posterior retinopathy of prematurity (ROP).
METHODS—48 eyes of 25 premature babies (mean birth weight 779 (SD 127.7) g; mean gestational age 25.5 (SD 1.47) weeks) with threshold ROP in zone I and posterior zone II were treated by the indirect infrared (810 nm) diode laser. Confluent burns were applied to the avascular retina. In 18 eyes, an additional row of laser burns was added posterior to the ridge.
RESULTS—Favourable anatomical results were noted in 41 eyes (85.4%). ROP stage 5 developed in two eyes, ROP stage 4A developed in four eyes, and ROP stage 4B in one eye. Three of the eyes with stage 4A eyes were successfully buckled; the fourth was not operated on and remained demarcated by laser scars. No complications were noted.
CONCLUSION—In this series, the diode laser was found to be a safe and effective treatment for posterior ROP.



Full Text

The Full Text of this article is available as a PDF (106.8 KB).

Figure 1  .

Figure 1  

Open in a new tab

Schematic drawing showing the zones of the premature fundus, according to the CRYO-ROP study.1 The broken circle represents the anterior border of posterior zone II, located one disc diameter peripheral to the anterior border of zone I. 

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Banach M. J., Ferrone P. J., Trese M. T. A comparison of dense versus less dense diode laser photocoagulation patterns for threshold retinopathy of prematurity. Ophthalmology. 2000 Feb;107(2):324–328. doi: 10.1016/s0161-6420(99)00042-1. [DOI] [PubMed] [Google Scholar]
  2. Capone A., Jr, Diaz-Rohena R., Sternberg P., Jr, Mandell B., Lambert H. M., Lopez P. F. Diode-laser photocoagulation for zone 1 threshold retinopathy of prematurity. Am J Ophthalmol. 1993 Oct 15;116(4):444–450. doi: 10.1016/s0002-9394(14)71402-3. [DOI] [PubMed] [Google Scholar]
  3. Connolly B. P., McNamara J. A., Sharma S., Regillo C. D., Tasman W. A comparison of laser photocoagulation with trans-scleral cryotherapy in the treatment of threshold retinopathy of prematurity. Ophthalmology. 1998 Sep;105(9):1628–1631. doi: 10.1016/S0161-6420(98)99029-7. [DOI] [PubMed] [Google Scholar]
  4. Dorey C. K., Aouididi S., Reynaud X., Dvorak H. F., Brown L. F. Correlation of vascular permeability factor/vascular endothelial growth factor with extraretinal neovascularization in the rat. Arch Ophthalmol. 1996 Oct;114(10):1210–1217. doi: 10.1001/archopht.1996.01100140410008. [DOI] [PubMed] [Google Scholar]
  5. Fleming T. N., Runge P. E., Charles S. T. Diode laser photocoagulation for prethreshold, posterior retinopathy of prematurity. Am J Ophthalmol. 1992 Nov 15;114(5):589–592. doi: 10.1016/s0002-9394(14)74488-5. [DOI] [PubMed] [Google Scholar]
  6. Hindle N. W., Leyton J. Prevention of cicatricial retrolental fibroplasia by cryotherapy. Can J Ophthalmol. 1978 Oct;13(4):277–282. [PubMed] [Google Scholar]
  7. Landers M. B., 3rd, Semple H. C., Ruben J. B., Serdahl C. Argon laser photocoagulation for advanced retinopathy of prematurity. Am J Ophthalmol. 1990 Oct 15;110(4):429–431. doi: 10.1016/s0002-9394(14)77029-1. [DOI] [PubMed] [Google Scholar]
  8. McGregor M. L., Wherley A. J., Fellows R. R., Bremer D. L., Rogers G. L., Letson A. D. A comparison of cryotherapy versus diode laser retinopexy in 100 consecutive infants treated for threshold retinopathy of prematurity. J AAPOS. 1998 Dec;2(6):360–364. doi: 10.1016/s1091-8531(98)90035-0. [DOI] [PubMed] [Google Scholar]
  9. McNamara J. A., Tasman W., Brown G. C., Federman J. L. Laser photocoagulation for stage 3+ retinopathy of prematurity. Ophthalmology. 1991 May;98(5):576–580. doi: 10.1016/s0161-6420(91)32247-4. [DOI] [PubMed] [Google Scholar]
  10. McNamara J. A., Tasman W., Vander J. F., Brown G. C. Diode laser photocoagulation for retinopathy of prematurity. Preliminary results. Arch Ophthalmol. 1992 Dec;110(12):1714–1716. doi: 10.1001/archopht.1992.01080240054029. [DOI] [PubMed] [Google Scholar]
  11. Noonan C. P., Clark D. I. Trends in the management of stage 3 retinopathy of prematurity. Br J Ophthalmol. 1996 Apr;80(4):278–281. doi: 10.1136/bjo.80.4.278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. O'Keefe M., Burke J., Algawi K., Goggin M. Diode laser photocoagulation to the vascular retina for progressively advancing retinopathy of prematurity. Br J Ophthalmol. 1995 Nov;79(11):1012–1014. doi: 10.1136/bjo.79.11.1012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. O'Keefe M., O'Reilly J., Lanigan B. Longer-term visual outcome of eyes with retinopathy of prematurity treated with cryotherapy or diode laser. Br J Ophthalmol. 1998 Nov;82(11):1246–1248. doi: 10.1136/bjo.82.11.1246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Pearce I. A., Pennie F. C., Gannon L. M., Weindling A. M., Clark D. I. Three year visual outcome for treated stage 3 retinopathy of prematurity: cryotherapy versus laser. Br J Ophthalmol. 1998 Nov;82(11):1254–1259. doi: 10.1136/bjo.82.11.1254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Pierce E. A., Foley E. D., Smith L. E. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch Ophthalmol. 1996 Oct;114(10):1219–1228. doi: 10.1001/archopht.1996.01100140419009. [DOI] [PubMed] [Google Scholar]
  16. Seiberth V., Linderkamp O., Vardarli I. Transscleral vs transpupillary diode laser photocoagulation for the treatment of threshold retinopathy of prematurity. Arch Ophthalmol. 1997 Oct;115(10):1270–1275. doi: 10.1001/archopht.1997.01100160440008. [DOI] [PubMed] [Google Scholar]
  17. Stone J., Chan-Ling T., Pe'er J., Itin A., Gnessin H., Keshet E. Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity. Invest Ophthalmol Vis Sci. 1996 Feb;37(2):290–299. [PubMed] [Google Scholar]
  18. Tasman W. Zone I retinopathy of prematurity. Arch Ophthalmol. 1985 Nov;103(11):1693–1694. doi: 10.1001/archopht.1985.01050110087032. [DOI] [PubMed] [Google Scholar]
  19. Tsitsis T., Tasman W., McNamara J. A., Brown G., Vander J. Diode laser photocoagulation for retinopathy of prematurity. Trans Am Ophthalmol Soc. 1997;95:231–245. [PMC free article] [PubMed] [Google Scholar]
  20. Vander J. F., Handa J., McNamara J. A., Trese M., Spencer R., Repka M. X., Rubsamen P., Li H., Morse L. S., Tasman W. S. Early treatment of posterior retinopathy of prematurity: a controlled trial. Ophthalmology. 1997 Nov;104(11):1731–1736. doi: 10.1016/s0161-6420(97)30034-7. [DOI] [PubMed] [Google Scholar]
  21. White J. E., Repka M. X. Randomized comparison of diode laser photocoagulation versus cryotherapy for threshold retinopathy of prematurity: 3-year outcome. J Pediatr Ophthalmol Strabismus. 1997 Mar-Apr;34(2):83–122. doi: 10.3928/0191-3913-19970301-06. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES